Authors
Loading...
Analysis reveals that circulating tumor DNA dynamics correlate with progression-free survival in patients with early-stage NKTCL, suggesting a potential for personalized treatment strategies.
Huang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: